Rachel Warren
Rachel Warren is a contributing Stock Market Analyst at The Motley Fool covering publicly traded companies across pharmaceuticals, biotechnology, medical devices, information technology, and consumer goods. Prior to The Motley Fool, Rachel worked as a digital marketing professional in the legal industry, and before that as a legal administrator and paralegal. She holds a Bachelor of Science in Paralegal Studies from Liberty University School of Law. Fun fact: Rachel spends a good chunk of the year in Italy, and when not writing about stocks can often be found trotting to some new corner of the globe. She has been to nearly 30 countries so far.
Recent Articles by Rachel Warren

What Are the Types of Investors? Overview and Examples

The Worst States to Retire in 2025

How to Invest in Vanguard Mid-Cap ETF (VO)

Investing in Travel and Tourism Stocks

Investing in Wheat Stocks

Investing in Restaurant Stocks

The Safest States to Retire in 2025

Got $1,000? 2 Top Growth Stocks to Buy Right Now

How to Invest in Vanguard Short-Term Bond ETF (BSV)

SPDR S&P Biotech ETF (XBI): How to Buy

Investing in Textile Stocks

Best Dividend ETFs of 2025
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.